The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Wardenaar, Klaas J.
  • dc.contributor.author Alonso Caballero, Jordi
  • dc.contributor.author Kessler, Ronald C.
  • dc.date.accessioned 2019-02-13T10:56:43Z
  • dc.date.available 2019-02-13T10:56:43Z
  • dc.date.issued 2014
  • dc.description.abstract BACKGROUND: Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods. However, it is not known whether these distinctions can be refined by added information about co-morbid conditions. The current report presents results on this question. METHOD: Data came from 8261 respondents with lifetime DSM-IV MDD in the World Health Organization (WHO) World Mental Health (WMH) Surveys. Outcomes included four retrospectively reported measures of persistence/severity of course (years in episode; years in chronic episodes; hospitalization for MDD; disability due to MDD). Machine learning methods (regression tree analysis; lasso, ridge and elastic net penalized regression) followed by k-means cluster analysis were used to augment previously detected subtypes with information about prior co-morbidity to predict these outcomes. RESULTS: Predicted values were strongly correlated across outcomes. Cluster analysis of predicted values found three clusters with consistently high, intermediate or low values. The high-risk cluster (32.4% of cases) accounted for 56.6-72.9% of high persistence, high chronicity, hospitalization and disability. This high-risk cluster had both higher sensitivity and likelihood ratio positive (LR+; relative proportions of cases in the high-risk cluster versus other clusters having the adverse outcomes) than in a parallel analysis that excluded measures of co-morbidity as predictors. CONCLUSIONS: Although the results using the retrospective data reported here suggest that useful MDD subtyping distinctions can be made with machine learning and clustering across multiple indicators of illness persistence/severity, replication with prospective data is needed to confirm this preliminary conclusion.
  • dc.description.sponsorship The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481). Peter de Jonge is supported by a VICI grant (no: 91812607) from the Netherlands Research Foundation (NWO-ZonMW). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey (L.E.B.A.N.O.N.) is supported by National Institute of Health / Fogarty International Center (R03 TW006481-01). The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H). The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study is funded by the US National Institute of Mental Health (RO1-MH61905). The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01- MH60220), the Robert Wood Johnson Foundation (RWJF; Grant 044708)
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J et al. The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychol Med. 2014 Nov;44(15):3289-302. DOI: 10.1017/S0033291714000993
  • dc.identifier.doi http://dx.doi.org/10.1017/S0033291714000993
  • dc.identifier.issn 0033-2917
  • dc.identifier.uri http://hdl.handle.net/10230/36580
  • dc.language.iso eng
  • dc.publisher Cambridge University Press
  • dc.relation.ispartof Psychological Medicine. 2014 Nov;44(15):3289-302
  • dc.rights © Cambridge University Press. The published version of the article: Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J et al. The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychol Med. 2014 Nov; 44(15): 3289-302 is available at http://dx.doi.org/10.1017/S0033291714000993
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.subject.other Comorbiditat
  • dc.subject.other Depressió psíquica
  • dc.subject.other Salut mundial
  • dc.title The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/acceptedVersion

Col·leccions

Articles (Departament de Medicina i Ciències de la Vida)
Articles (Hospital del Mar Research Institute)